Barclays raised the firm’s price target on Sapiens to $30 from $28 and keeps an Underweight rating on the shares. The company reported solid results with revenue growth in line with consensus estimates and a beat on earnings, the analyst tells investors in a research note. However, the firm sees limited share upside from here.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SPNS: